Zentek Ltd. (ZTEK)
Company Description
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada.
It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada.
The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound.
In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene.
The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021.
Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.
| Country | CA |
| IPO Date | Apr 2, 2012 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 24 |
| CEO | Gregory Fenton C.F.A. |
Contact Details
Address: 1205 Amber Drive Thunder Bay, ON CA | |
| Website | https://www.zentek.com |
Stock Details
| Ticker Symbol | ZTEK |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001904501 |
| CUSIP Number | 98942X102 |
| ISIN Number | CA98942X1024 |
| Employer ID | 00-0000000 |
| SIC Code | 2890 |
Key Executives
| Name | Position |
|---|---|
| Gregory Fenton C.F.A. | Chief Executive Officer & Director |
| Wendy Ford CA, CPA | Chief Financial Officer |
| Dr. Colin van der Kuur B.Sc., DMIN | Chief Science Officer |
| Ryan Shacklock | Senior Vice President of Strategy & Business Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 17, 2025 | 6-K | Filing |
| Jan 08, 2025 | 6-K | Filing |
| Dec 12, 2024 | 6-K | Filing |
| Dec 09, 2024 | 6-K | Filing |
| Nov 27, 2024 | 6-K | Filing |
| Nov 14, 2024 | 6-K | Filing |
| Nov 06, 2024 | 6-K | Filing |
| Oct 31, 2024 | 6-K | Filing |
| Oct 17, 2024 | 6-K | Filing |
| Sep 27, 2024 | 6-K | Filing |